The precise regulation of the immune system depends on the synergistic effect of clonal identity, functional state, and regulatory potential of lymphocytes, but it is difficult to completely analyze this complex network using traditional single-omics technology. As the core tool to analyze the characteristics of T cell receptor (TCR) and B cell receptor (BCR) clones, Immune repertoire sequencing can clarify the distribution of T cell clones through TCR-seq, capture the high-frequency mutation and clone amplification of B cell somatic cells through BCR-seq, and accurately answer which immune clones exist. Still, it cannot reveal the functional status (such as activation and depletion) and differentiation potential of these clones.
Transcriptomics can detect gene expression patterns and clarify the functional phenotype of immune cells; Epigenomics can analyze the characteristics of chromatin accessibility and methylation, and mine the regulatory network and pedigree history of cells. Integrating immune repertoire sequencing with them can not only lock antigen-specific clones through TCR-seq/BCR-seq, but also judge the functional state of clones with the help of transcriptomics, and trace their differentiation origin and response potential through epigenetics, thus forming a complete research chain of clone identity-functional state-regulatory mechanism. This multi-omics integration strategy completely breaks through the limitation of single technology, and provides key technical support for deeply understanding the immune response mechanism in infection, tumor, and autoimmune diseases, and promoting the development of precision immunotherapy.
The article discusses integrating immune repertoire sequencing with transcriptomics and epigenetics to analyze lymphocyte clonal identity, functional states, and regulatory mechanisms, supporting immune research and precision immunotherapy.
The function of the immune system depends on the regulation of lymphocytes, and the traditional immune repertoire sequencing technology has limitations, which can not meet the needs of in-depth research. In the study of tumor immunity, its limitations are particularly obvious.
Under this background, integrating V (D) J sequence data with transcriptome and epigenetics data has become the core strategy to break through this limitation. The core argument is that through the linkage analysis of multi-omics data, an unprecedented and integrated map of immune cell function, differentiation, and fate can be constructed. The three core components of this integrated research system have irreplaceable values:
The organic integration of the three can realize the complete chain analysis from cloned identity to functional state to "regulatory mechanism", and provide a new perspective for basic research and clinical transformation of immunity.
Analysis of CD8+ antigen-specific T cells sampled from Donor 1 (Samir et al., 2020)
Take the Next Step: Explore Related Services
Learn More
In traditional immune research, immune repertoire sequencing, transcriptome, and epigenetics are often carried out separately, which leads to the separation of information such as clone identity, cell state, and regulatory potential, and it is difficult to fully analyze the immune mechanism. Multiomics integration technology came into being, from single-cell synchronous capture to bulk sample cross-modal alignment, which broke through the limitation of a single dimension and realized the accurate correlation of different omics data, providing systematic technical support for revealing the function, differentiation, and fate of immune cells.
The emergence of single-cell multimethology technology has completely broken the limitations of traditional sample detection and data fragmentation, and achieved the synchronous capture of immune repertoire sequencing, transcriptome, epigenome, and protein expression information of the same cell, among which 10x genomics multiome combined with Feature Barcoding technology has become the mainstream platform for multi-dimensional immune research.
The core technical principle of this kind of platform is Cell Barcode sharing, that is, a single cell and a Gel Bead with a unique Cell Barcode are wrapped in the same droplet through microfluidic technology, so that all the data of the cell carries the same Barcode, and finally, the accurate correlation of multimodal data is realized through bioinformatics analysis. The specific process can be divided into three steps:
Multimodal biomarkers of immune cell states (Hao et al., 2021)
In addition to the single-cell synchronous capture technology, sequential analysis and aggregation analysis methods have become an important supplement to the integration of multi-omics, mainly including two strategies: bulk horizontal integration and cross-modal data alignment.
A. Bulk horizontal integration
a) This strategy is suitable for the research that needs in-depth analysis of specific cell subsets, and the core process is cell sorting → sample analysis → data association. Specifically, the target cell subsets (such as CD8+T cells and CD19+B cells) were separated from the bulk samples by flow cytometry or magnetic bead sorting technology, and then the same subset was subjected to Bulk Immunization Repeater Sequencing and bulk RNA-seq, respectively. Finally, the characteristics of clone amplification and the differences in gene expression were correlated by statistical methods.
b) The advantage of this method is that it can achieve in-depth detection of specific subgroups. For example, bulk RNA-seq can detect low-expression genes (such as transcription factor genes), while single-cell technology may miss such information due to the limitation of sequencing depth. However, the disadvantage is that the accurate correlation at the single cell level can not be realized, and it can only reflect the average characteristics at the population level, and the cell sorting process may lead to the change of activation state of some cells, which may affect the authenticity of the data.
B. Cross-modal Data Alignment
a) When the sample size is very small (such as a puncture biopsy tissue), it is impossible to carry out cell sorting or multiple tests. A cross-modal data alignment strategy can solve the contradiction between insufficient sample size and multiple omics requirements by carrying out different omics tests on different aliquots of the same sample, and then using computing tools to realize data integration.
b) The specific process is as follows: Divide an original sample (for example, 10^5 PBMCs) into 2-3 aliquots on average, respectively:
c) Then, using computational integration algorithms (such as CCA integration of Seurat, Harmony, LIGER), the cells of different aliquots were matched based on cell clustering markers or similarity of gene expression/apparent characteristics.
d) The key to this method is to choose an appropriate integration Anchor to ensure the consistency of cell grouping of different aliquots. In the study of tumor-infiltrating lymphocytes, the expression patterns of surface markers such as "CD3, CD8, CD4, PD-1" can be used as anchor points, which can effectively reduce the cell grouping deviation caused by the difference in sample processing, and the integration accuracy can reach 80%-90%. However, its limitation is that it depends on the reliability of the calculation model. If there is a large heterogeneity among aliquots (such as a high proportion of apoptosis in some aliquots), the integration results may be distorted.
Investigating immune repertoire and transcriptional features of TNFR2-specific BM PCs (Agrafiotis et al., 2023)
The integration of immune repertoire sequencing and transcriptomics (cell state) fills the information gap between the identity and functional state of immune clones, and provides key evidence for analyzing antigen-specific immune response, clone differentiation trajectory, and gene regulation network. The following is elaborated from three core directions.
Repertoire behavior in the vaccination time course (Pavlova et al., 2024)
Immune repertoire sequencing is used to identify the clonal identity of lymphocytes, while epigenetic techniques (such as single-cell ATAC-seq and DNA methylation sequencing) are used to analyze the gene expression regulation mechanism and cell lineage history. The integration of the two provides a core technical means for explaining the mechanism of functional specialization and fate determination mediated by epigenetic regulation of immune clones. The core findings can be expounded from the following three aspects.
Prediction of differentiation potential of memory B cell clones after vaccine immunization: immune repertoire sequencing recognizes HPV vaccine-specific BCR clones, and histone modification sequencing shows that the modification level of the antibody secretion gene promoter region H3K4me3 can accurately predict the antibody secretion ability of clones.
Apparent early warning of abnormal differentiation clones in autoimmune diseases: In the high-risk population of rheumatoid arthritis, immune repertoire sequencing detected potentially pathogenic BCR clones, and ATAC-seq showed that chromatin in the enhancer region of pro-inflammatory genes was open, which could be used as an early warning signal of abnormal differentiation of clones.
Apparent traceability of tumor antigen through T cell cloning: In PBMCs of lung cancer patients, Immune repertoire sequencing found that specific TCR clones existed in peripheral blood and tumor tissues. Combined with DNA methylation sequencing, it was confirmed that hypomethylation of the tumor antigen response gene promoter from tumor clones was an apparent sign of tumor antigen stimulation, which could trace the infiltration history.
Prediction of differentiation potential of memory B-cell clones after vaccination: immune repertoire sequencing recognizes specific BCR clones among HPV vaccine recipients, and histone modification sequencing shows that the modification level of the antibody secretion gene promoter region H3K4me3 can accurately predict the antibody secretion ability of clones.
Apparent early warning of abnormal differentiation clones in autoimmune diseases: In the high-risk population of rheumatoid arthritis, immune repertoire sequencing detected potentially pathogenic BCR clones, and ATAC-seq showed that chromatin in the enhancer region of pro-inflammatory genes was open, which could be used as an early warning signal of abnormal differentiation of clones.
Tregs exhibit position-specific TCR sequence features (Kaitlyn et al., 2021)
To sum up, the integration of Immune repetoire sequencing with transcriptomics and Epigenomics breaks through the information limitation of single technology, and constructs a complete research chain of cloning identity-functional state-regulation mechanism: the clone specificity provided by Immune repetoire sequencing anchors the core target of multi-group association, transcriptomics reveals the molecular basis of cell functional phenotype, and Epigenomics analyzes the deep logic and cell lineage history of gene expression regulation.
This multi-dimensional integration not only deepens the understanding of the dynamic evolution of immune response, the specialization of cloning function, and the fate determination mechanism, but also provides a precise control idea for solving clinical problems (such as immunotherapy resistance and the traceability of autoimmune diseases). In the future, with the standardization of technology and the optimization of analytical tools, this integration strategy will further promote the transformation of basic immune research into the clinic, and provide more powerful theoretical and technical support for precise intervention of immune-related diseases.
ABC company offers specialized end-to-end services to empower your research, providing you with the deep, mechanistic insights that only integrated analysis can deliver. Contact now to discuss how our multi-omics sequencing services can provide the missing links in your immunological research and drive your projects forward.
References
CD Genomics is transforming biomedical potential into precision insights through seamless sequencing and advanced bioinformatics.